Home
>
National Drug Code (NDC)
>
Cisplatin
Cisplatin - 0069-0081-01 - (Cisplatin)
Drug Information of Cisplatin
| Product NDC: | 0069-0081 |
| Proprietary Name: | Cisplatin |
| Non Proprietary Name: | Cisplatin |
| Active Ingredient(s): | 1 mg/mL & nbsp; Cisplatin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cisplatin
| Product NDC: | 0069-0081 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091062 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120419 |
Package Information of Cisplatin
| Package NDC: | 0069-0081-01 |
| Package Description: | 100 mL in 1 VIAL (0069-0081-01) |
NDC Information of Cisplatin
| NDC Code | 0069-0081-01 |
| Proprietary Name | Cisplatin |
| Package Description | 100 mL in 1 VIAL (0069-0081-01) |
| Product NDC | 0069-0081 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cisplatin |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120419 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
| Substance Name | CISPLATIN |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
